Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes

Cited by (202)

Items 101–200 of 202

1. Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
   Aarti Tiwari, Saloni Rahi, Sidharth Mehan · 2020 · Current Drug Targets
2. Circadian activities of the brain MNK‐eIF4E signalling axis contribute to diurnal rhythms of some cognitive functions
   Dong Liu, Jin Li, Hao Lin, Ethan Lorsung, Nam Le, Rubal Singla, Abhishek Mishra, Rikiro Fukunaga, Ruifeng Cao · 2022 · European Journal of Neuroscience
3. Medicinal chemistry approaches to target the MNK–eIF4E axis in cancer
   Ann Fernandez, Paige J. Monsen, Leonidas C. Platanias, Gary E. Schiltz · 2023 · RSC Medicinal Chemistry
4. Impact of matrix metalloproteinase-9 overexpression on synaptic excitatory transmission and its plasticity in rat CA3-CA1 hippocampal pathway.
   Grzegorz Wiera, Marcin Szczot, Tomasz Wójtowicz, Katarzyna Lebida, Paulina Koza, Jerzy Wladyslaw Mozrzymas · 2015 · PubMed
5. AAV‐delivered diacylglycerol kinase DGKk achieves long‐term rescue of fragile X syndrome mouse model
   Karima Habbas, Oktay Cakil, Boglárka Zámbó, Ricardos Tabet, Fabrice Riet, Doulaye Dembélé, Jean‐Louis Mandel, Michaël Hocquemiller, Ralph Laufer, Françoise Piguet et al. · 2022 · EMBO Molecular Medicine
6. eIF4E phosphorylation recruits β-catenin to mRNA cap and promotes Wnt pathway translation in dentate gyrus LTP maintenance
   Sudarshan S. Patil, K. Chalkiadaki, T. F. Mergiya, Konstanze Krimbacher, Inês S. Amorim, Shreeram Akerkar, C. Gkogkas, C. Bramham · 2023 · iScience
7. A Clinically Relevant Selective ERK-Pathway Inhibitor Reverses Core Deficits in a Mouse Model of Autism
   Kartikeya Murari, Abdulrahman Abushaibah, Jong M. Rho, Ray W. Turner, Ning Cheng · 2022 · EBioMedicine
8. Dysregulation of translational control signaling in autism spectrum disorders
   Mehdi Hooshmandi, Calvin Wong, Arkady Khoutorsky · 2020 · Cellular Signalling
9. Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment
   Verica Vasić, Mattson S. O. Jones, Denise Haslinger, Lisa S. Knaus, Michael J. Schmeißer, Gaia Novarino, Andreas G. Chiocchetti · 2021 · Genes
10. Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma
    Sakibul Huq, Nivedha V. Kannapadi, Joshua Casaos, Tarik Lott, Raphael Felder, Riccardo Serra, Noah Leviton Gorelick, Miguel Angel Ruiz-Cardozo, Andy S. Ding, Arba Firdus Cecia et al. · 2021 · Journal of Neurosurgery Pediatrics
11. Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial
    Champigny, Camille, Morin-Parent, Florence, Bellehumeur-Lefebvre, Laurence, Çaku, Artuela, Lepage, Jean-François, Corbin, François · 2022 · Frontiers in Psychiatry
12. A Hydroxypyrone-Based Inhibitor of Metalloproteinase-12 Displays Neuroprotective Properties in Both Status Epilepticus and Optic Nerve Crush Animal Models
    Jonathan Vinet, Anna‐Maria Costa, Manuel Salinas‐Navarro, Giuseppina Leo, Lieve Moons, Lut Arckens, Giuseppe Biagini · 2018 · International Journal of Molecular Sciences
13. A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in Mice
    Tarjani N. Shukla, June Bryan de la Peña, John M. Perish, Jonathan E. Ploski, Craig R. Stumpf, Kevin R. Webster, Catherine A. Thorn, Zachary T. Campbell · 2020 · Neurotherapeutics
14. Mnk1/2 kinases regulate memory and autism-related behaviours via Syngap1
    Kleanthi Chalkiadaki, Mehdi Hooshmandi, Gilliard Lach, Elpida Statoulla, Konstanze Simbriger, Inês S. Amorim, Stella Kouloulia, Maria Zafeiri, Panagiotis Pothos, Éric Bonneil et al. · 2022 · Brain
15. Chronic Intermittent Ethanol Exposure Induces Upregulation of Matrix Metalloproteinase-9 in the Rat Medial Prefrontal Cortex and Hippocampus
    Litian Yin, Fengqing Li, Jue Li, Xiaorong Yang, Xiaoyan Xie, Linyuan Xue, Yanli Li, Ce Zhang · 2019 · Neurochemical Research
16. Neuroligins in neurodevelopmental conditions: how mouse models ofde novomutations can help us link synaptic function to social behavior
    Tobias T. Pohl, Hanna Hörnberg · 2022 · Neuronal Signaling
17. Of local translation control and lipid signaling in neurons
    Hervé Moine, Nicolas Vitale · 2018 · Advances in Biological Regulation
18. Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge
    Simone Carotti, Maria Zingariello, Maria Angela Francesconi, Laura D’Andrea, Maria Ujue Latasa, Leticia Colyn, Maite G. Fernández‐Barrena, Rocco Simone Flammia, Mario Falchi, Daniela Righi et al. · 2021 · Oncogene
19. Translation from the Ribosome to the Clinic: Implication in Neurological Disorders and New Perspectives from Recent Advances
    Kelvin K. Hui, YiKai Chen, Ryo Endo, Motomasa Tanaka · 2019 · Biomolecules
20. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation
    Zhenzhou Huang, Yanjie Tan · 2023 · International Journal of Molecular Sciences
21. Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome
    Mittal Jasoliya, Heather L. Bowling, Ignacio Cortina Petrasic, Blythe P Durbin-Johnson, Eric Klann, Aditi Bhattacharya, Randi Jenssen Hagerman, Flora Tassone · 2020 · Brain Sciences
22. Therapeutic targeting of eukaryotic initiation factor (eIF) 4E
    Jerry Pelletier, Nahum Sonenberg · 2023 · Biochemical Society Transactions
23. mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS
    Vipendra Kumar, Kwan Young Lee, Anirudh Acharya, Matthew S Babik, Catherine A. Christian, Justin S. Rhodes, Nien‐Pei Tsai · 2024 · EMBO Molecular Medicine
24. Alteration of synaptic protein composition during developmental synapse maturation
    Takeshi Kaizuka, Toru Takumi · 2024 · European Journal of Neuroscience
25. Persistent changes in the dorsal root ganglion nociceptor translatome governs hyperalgesic priming in mice: roles of GPR88 and Meteorin
    Ishwarya Sankaranarayanan, Moeno Kume, Ayaan Mohammed, Juliet M. Mwirigi, Nikhil Nageshwar Inturi, Gordon Munro, Kenneth Ahrend Petersen, Diana Tavares‐Ferreira, Theodore John Price · 2025 · Pain
26. Targeted therapy of cognitive deficits in fragile X syndrome
    Alicja Puścian, Maciej J. Winiarski, Joanna Borowska, Szymon Łęski, Tomasz Górkiewicz, Mayank Chaturvedi, Klaudia Nowicka, Maria Wołyniak, Joanna J. Chmielewska, Tomasz Nikolaev et al. · 2022 · Molecular Psychiatry
27. The tetrapartite synapse in neuropsychiatric disorders: Matrix metalloproteinases (MMPs) as promising targets for treatment and rational drug design
    Adriano José Maia Chaves Filho, Melina Mottin, Deniele Bezerra Lós, Carolina Horta Andrade, Danielle S. Macêdo · 2022 · Biochimie
28. Od c-Fos do MMP-9 w kontroli plastyczności synaptycznej zdrowego i chorego umysłu, spojrzenie osobiste
    Leszek Kaczmarek · 2018 · Postępy Biochemii
29. A metabolite of endophytic fungus Cadophora orchidicola from Kalimeris indica serves as a potential fungicide and TLR 4 agonist
    L. Wang, Jia‐Wei Shen, L. Xu, Jianqing Gao, C. Zhang, Yating Wang, Fengyang Chen · 2019 · Journal of Applied Microbiology
30. MNK1 and MNK2 Expression in the Human Dorsal Root and Trigeminal Ganglion
    Stephanie I. Shiers, James J. Sahn, Theodore John Price · 2023 · Neuroscience
31. Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury
    Trevor S. Wendt, Rayna J. Gonzales · 2023 · American Journal of Physiology-Cell Physiology
32. RNA ‐binding proteins in pain
    Patrick R. Smith, Zachary T. Campbell · 2024 · Wiley Interdisciplinary Reviews - RNA
33. Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer
    Cristiano Ferrario, John Robert Mackey, Karen A. Gelmon, Nathalie LeVasseur, Poul H. B. Sorensen, Htoo Zarni Oo, Gian Luca Negri, Veronica W.L. Tse, Sandra E. Spencer Miko, Grace S. W. Cheng et al. · 2024 · Clinical Cancer Research
34. Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
    Asma Laroui, Luc Galarneau, Armita Abolghasemi, Sérine Benachenhou, Rosalie Plantefève, Fatima Zahra Bouchouirab, Jean‐François Lepage, François Corbin, Artuela Çaku · 2022 · Scientific Reports
35. The mGluR Theory of Fragile X: From Mice to Men
    Laura J. Stoppel, Emily K. Osterweil, Mark F. Bear · 2017 · Elsevier eBooks
36. A new strategy to uncover fragile X proteomic biomarkers using the nascent proteome of peripheral blood mononuclear cells (PBMCs)
    Olivier Dionne, François Corbin · 2021 · Scientific Reports
37. Translating from cancer to the brain: regulation of protein synthesis by eIF4F
    Ilona R. Kats, Eric Klann · 2019 · Learning & Memory
38. Neurobehavioral features and targeted treatments in fragile X syndrome: Current insights and future directions
    Dejan B. Budimirovic, Phan Q. Duy · 2015 · Engrami
39. Discovery of novel indole derivatives as potent and selective inhibitors of proMMP-9 activation
    Rie Nishikawa‐Shimono, Motoi Kuwabara, Sho Fujisaki, Daisuke Matsuda, Mayumi Endo, Masafumi Kamitani, Aya Futamura, Yusaku Nomura, Toru Yamaguchi-Sasaki, Tetsuya Yabuuchi et al. · 2023 · Bioorganic & Medicinal Chemistry Letters
40. MMP-9 in Control of Synaptic Plasticity: a Subjective Account
    Leszek Kaczmarek · 2016 · Russian Agency for Digital Standardization
41. Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome
    Celeste Ferraguto, Marion Piquemal, Valérie Lemaire, Maïté Marie Moreau, Stefania Trazzi, Beatrice Uguagliati, Elisabetta Ciani, Sandrine S. Bertrand, Eric Louette, Bruno Bontempi et al. · 2024 · Neuropsychopharmacology
42. Regulation of mRNA translation in stem cells; links to brain disorders.
    Elpida Statoulla, K. Chalkiadaki, Dimitris Karozis, C. Gkogkas · 2021 · Cellular Signalling
43. Translation regulation in the spinal dorsal horn – A key mechanism for development of chronic pain
    Shannon N. Tansley, Calvin Wong, Sonali Uttam, Jeffrey S. Mogil, Arkady Khoutorsky · 2018 · Neurobiology of Pain
44. From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research
    Mathijs B. van der Lei, R. Frank Kooy · 2025 · Biomedicines
45. FMRP Enhances the Translation of 4EBP2 mRNA during Neuronal Differentiation
    Jinbae Yu, Youngsik Woo, Heesun Kim, Sihyeon An, Sang Ki Park, Sung Key Jang · 2023 · International Journal of Molecular Sciences
46. A Differential Effect of Lovastatin versus Simvastatin in Neurodevelopmental Disorders
    Melania Muscas, Sang S. Seo, Susana R. Louros, Emily K. Osterweil · 2020 · eNeuro
47. Matrix metalloproteinase 9: An emerging biomarker for classification of adherent vestibular schwannoma
    Han T. N. Nguyen, Bailey H. Duhon, Hsuan-Chih Kuo, Melanie Fisher, Olivia M Brickey, Lisa Zhang, José Javier Otero, Daniel M. Prevedello, Oliver F. Adunka, Yin Ren · 2024 · Neuro-Oncology Advances
48. The Use of Peptides in the Treatment of Fragile X Syndrome: Challenges and Opportunities
    Alice Romagnoli, Daniele Di Marino · 2021 · Frontiers in Psychiatry
49. The cleavage of host cell proteins by HIV-1 protease.
    Václav Snåšel, I. (Iva) Pichová · 1996 · PubMed
50. Neurophysiological effects of a combined treatment of lovastatin and minocycline in patients with fragile X syndrome: Ancillary results of the LOVAMIX randomized clinical trial
    Florence Morin‐Parent, Camille M. Champigny, Samantha Rae Cote, Teddy Mohamad, Seyede Anis Hasani, Artuela Çaku, François Corbin, Jean‐François Lepage · 2024 · Autism Research
51. 3Rs-based optimization of mice behavioral testing: The habituation/dishabituation olfactory test
    Asma Oummadi, Géraldine Meyer-Dilhet, Amandine Béry, Arnaud Aubert, Pascal R. Barone, Stéphane Mortaud, Gilles J. Guillemin, Arnaud Menuet, Anthony Laugeray · 2019 · Journal of Neuroscience Methods
52. Advances in understanding and targeting eIF4E activity
    Sabrina D’Agostino, Caitlin Davies, Marissa V. Powers, Paul Andrew Clarke · 2025 · Biochemical Society Transactions
53. Strategies to Advance Drug Discovery in Rare Monogenic Intellectual Disability Syndromes
    Nuwan C. Hettige, Karla Manzano-Vargas, Malvin Jefri, Carl Ernst · 2017 · The International Journal of Neuropsychopharmacology
54. A roadmap for neurodevelopmental disease modeling for non-stem cell biologists
    Carl Ernst · 2020 · Stem Cells Translational Medicine
55. Regulation of Protein Synthesis by eIF4E in the Brain
    Kleanthi Chalkiadaki, Stella Kouloulia, Clive R. Bramham, Christos G. Gkogkas · 2020 · Oxford University Press eBooks
56. Effects of Metformin on children with Fragile X Syndrome: a randomized, double-blind, placebo-controlled trial
    Yiting Zhu, Dongyun Li, Chunchun Hu, Yuxin Tian, Ping Lu, Randi Jenssen Hagerman, Xiu Xu, Qiong Xu · 2025 · Molecular Autism
57. Uncovering novel endocannabinoidome-gut microbiome-brain axis-based therapeutic targets in a Fragile X Syndrome mouse model
    Antonella Campanale, Hayatte-Dounia Mir, Elizabeth Dumais, Antonio Inserra, Nicolas Flamand, M. Mallar Chakravarty, Ilse Gantois, Nadeem. Siddiqui, Nahum Sonenberg, Gabriella Gobbi et al. · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
58. Growth-suppressor microRNAs mediate synaptic overgrowth and behavioral deficits in Fragile X mental retardation protein deficiency
    Megha P. Subramanian, William T. Mills, Manish D. Paranjpe, Uche S Onuchukwu, Manasi Inamdar, Amanda R Maytin, Xinbei Li, Joel L. Pomerantz, Mollie K. Meffert · 2023 · iScience
59. Alterations in auditory midbrain processing is observed in both female and male mouse model of Fragile X Syndrome
    Abdullah Abdullah, Xiuping Liu, Kartikeya Murari, Jun Yan, Ning Cheng · 2025 · Neuroscience
60. Synaptic cell adhesion molecules contribute to the pathogenesis and progression of fragile X syndrome
    Shu-Yuan Bai, De-Yang Zeng, Ming Ouyang, Yan Zeng, Wei Tan, Lang Xu · 2024 · Frontiers in Cellular Neuroscience
61. Intracellular Signaling Networks in Fragile X Syndrome: Approaches to Drug Discovery and Therapeutics
    Christina Groß, Aditi Bhattacharya · 2017 · Elsevier eBooks
62. Nociceptor translational profiling reveals the RagA-mTORC1 network as a critical generator of neuropathic pain
    Salim Megat, Pradipta R. Ray, Jamie K. Moy, Tzu‐Fang Lou, Paulino Barragán‐Iglesias, Yan Li, Grishma Pradhan, Andi Wangzhou, Ayesha Ahmad, Robert Y. North et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
63. Pioglitazone improves deficits of Fmr1 -KO mouse model of Fragile X syndrome by interfering with excessive diacylglycerol signaling
    Andréa Geoffroy, Karima Habbas, Boglárka Zámbó, Laetitia Schramm, Arnaud Duchon, Eric Flatter, Laëtitia Fouillen, Julie Zumsteg, Dimitri Heintz, Jean‐Louis Mandel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
64. Cell type-specific disruption of cortico-striatal circuitry drives repetitive patterns of behaviour in fragile X syndrome model mice
    Francesco Longo, Sameer Aryal, Paul G. Anastasiades, Marta Maltese, Corey Baimel, Federica Albanese, Joanna Tabor, Jeffrey D. Zhu, Mauricio Martins Oliveira, Denise Gastaldo et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
65. Differential effects of sound repetition rate on auditory cortex development and behavior in fragile X syndrome mouse model
    A.O. Norman, Nadia Farooq, Anuj Sahni, K. Tapia, D Breiner, Khaleel A. Razak, Iryna M. Ethell · 2025 · Experimental Neurology
66. PACAP, VIP, and ADNP: Autism and Schizophrenia
    Illana Gozes · 2016 · Current topics in neurotoxicity
67. Serum matrix metalloproteinase-9 (MMP9) and amyloid-beta protein precursor (APP) as potential biomarkers in children with Fragile-X syndrome: A cross sectional study
    Mohamed Bekheet, Lamiaa Ali Mansour, Rasha H. Elkaffas, Mona Ahmed Kamel, Mohamed A. Elmonem · 2023 · Clinical Biochemistry
68. How dendritic spines shape is determined by MMP-9 activity in FXS
    Magdalena Dziembowska · 2023 · International review of neurobiology
69. Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder
    Jan C. Schroeder, Elena Deliu, Gaia Novarino, Michael J. Schmeißer · 2017 · Advances in anatomy, embryology and cell biology
70. Matrix Metalloproteinases in Fragile X Syndrome
    Douglas W. Ethell, Harpreet Sidhu · 2017 · Elsevier eBooks
71. EZH2 inhibition reactivates epigenetically silenced FMR1 and normalizes molecular and electrophysiological abnormalities in fragile X syndrome neurons
    Minggang Fang, Sara K. Deibler, Pranathi Meda Krishnamurthy, Feng Wang, Paola María Rodríguez, Shahid Banday, Ching-Man A. Virbasius, Miguel Sena‐Esteves, Jonathan K. Watts, Michael R. Green · 2024 · Frontiers in Neuroscience
72. Distinct roles for MNK1 and MNK2 in social and cognitive behavior through kinase-specific regulation of the synaptic proteome and phosphoproteome
    Rosalba Olga Proce, Maria Steinecker, Chiara Giacomelli, Erika Uddstrom, Anirban Chatterjee, Souhaila Wusthoff, Luiz Gustavo Teixeira Alves, Oliver Popp, Tobias T. Pohl, Katie Maxwell et al. · 2026 · Molecular Psychiatry
73. Recent Updates in Treatment of Diabetic Neuropathy
    Mangreed M. Atef, Norhan Mohamed El-Sayed, Yasser Mostafa, Amal Ahmed · 2019 · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences
74. [Research advances in the role of mTOR signaling pathway in autism spectrum disorder].
    Guoxia Sheng, Kewen Jiang · 2019 · PubMed Central
75. Synaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model
    Pei Zhang · 2018
76. Ribosome Biogenesis and its Role in Cell Growth and Proliferation in the Liver
    Katherine I. Farley‐Barnes, Susan J. Baserga · 2020
77. AAV-delivery of diacylglycerol kinase kappa achieves long-term rescue of Fmr1 -KO mouse model deficits of fragile X syndrome
    Karima Habbas, Oktay Cakil, Boglárka Zámbó, Ricardos Tabet, Fabrice Riet, Doulaye Dembélé, Jean‐Louis Mandel, Michaël Hocquemiller, Ralph Laufer, Françoise Piguet et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
78. Correction of eIF4E overactivation rescues translatome imbalance and core ASD-like behaviors in valproic acid-induced offspring mice
    Miaoqi Huang, Han Ye, Yong Xu, Jiaoyan Xie, xinyu wang, Yan Luo, Peng Liu, Xuanyue Ma, Shiqing Zhang, Bin Jiang et al. · 2026 · Molecular Psychiatry
79. Research delves into role of key proteins in fragile X syndrome
    Deborah Levenson · 2015 · American Journal of Medical Genetics Part A
80. FMRP and the Pathophysiology of Fragile X Syndrome
    Stephanie A. Barnes, Sophie R. Thomson, Peter C. Kind, Emily K. Osterweil · 2016 · Elsevier eBooks
81. Virus-mediated Delivery of the Fmr1 Gene as a Tool for the Treatment of Fragile X Syndrome
    Shervin Gholizadeh Moghaddam · 2016 · TSpace (University of Toronto)
82. PROTEASE INDUCED PLASTICITY: MATRIX METALLOPROTEINASE-1 ACTIVATION OF PROTEASE ACTIVATED RECEPTOR 1 INDUCES NEURONAL STRUCTURAL PLASTICITY
    Megan Allen · 2017 · DigitalGeorgetown (Georgetown University Library)
83. Regulation of Local Translation, Synaptic Plasticity, and Cognitive Function by CNOT7
    Rhonda L. McFleder · 2017 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
84. The Use of Synaptosomes in Studying Autism Spectrum Disorder and Other Neurodevelopmental Disorders
    Nadeem Murtaza, Vickie Kwan, Biren M. Dave, Karun Kar Singh · 2018 · Neuromethods
85. Neuronal mRNA Translation in Addiction
    Emma Puighermanal, Emmanuel Valjent · 2018 · Oxford University Press eBooks
86. De novo protein synthesis in distinct centrolateral amygdala interneurons is required for associative emotional memories
    Prerana Shrestha, Zhe Shan, Maggie Marmarcz, Karen San Agustin Ruiz, Adam Taye Zerihoun, Chien-Yu Juan, Pedro Herrero-Vidal, Jerry Pelletier, Nathaniel Heintz, Eric Klann · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
87. Dysregulated Translation in Autism Spectrum Disorder
    Emanuela Santini, Anders Borgkvist · 2020 · Oxford University Press eBooks
88. Effective inhibition of MYC-amplified Group 3 medulloblastoma through targeting translation machinery eIF4F complex
    Yang Zhao, Tiantian Li, Shuaiwei Tian, Wei Meng, Jian Yang, Baocheng Wang, Zhuangzhuang Liang, Heng Zhao, Yipeng Han, Yujie Tang et al. · 2020
89. A New Strategy to Uncover Fragile X Proteomic Biomarkers Using the Nascent Proteome of Peripheral Blood Mononuclear Cells (PBMCs)
    Olivier Dionne, François Corbin · 2021 · Research Square
90. Ozanimod Attenuates Human Cerebrovascular Endothelial Derived MMP-9 Activity and Preserves Barrier Properties Following In Vitro Acute Ischemic Injury
    Trevor S. Wendt, Rayna J. Gonzales · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
91. Oligodendroglia and myelin pathology in fragile X syndrome
    Shaima Hourani, Mahmoud A. Pouladi · 2024 · Journal of Neurochemistry
92. Persistent changes in nociceptor translatomes govern hyperalgesic priming in mouse models
    Ishwarya Sankaranarayanan, Moeno Kume, Ayaan Mohammed, Juliet M. Mwirigi, Nikhil Nageshwar Inturi, Gordon Munro, Kenneth Ahrend Petersen, Diana Tavares‐Ferreira, Theodore John Price · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
93. Vitamin D regulates olfactory function via dual transcriptional and mTOR-dependent translational control of synaptic proteins
    Ren Pengcheng, Cao Renhe, Xiayan Ye, Pang Wenbin, Qingshang Bi, Meihui Huang, Qionglin Zhou, Dan Ye, Xiang Wei, Le Xiao · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
94. Combined Treatment with Minocycline and an mGluR5 Antagonist Alters Resting EEG Spectral Power, but Not Sound-Evoked Responses, in a Mouse Model of Fragile X Syndrome
    M. H. Kassir, Jonathan W. Lovelace, Devin K. Binder, Iryna M. Ethell, Khaleel A. Razak · 2025 · ASN NEURO
95. The E-Protein Daughterless Regulates Olfactory Learning of Adult Drosophila melanogaster
    Laura Tamberg, Carl Sander Kiir, Jürgen Tuvikene, Käthy Rannaste, Mari Palgi, Indrek Koppel, Tõnis Timmusk · 2026 · eNeuro
96. Synaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model
    Pei Zhang · 2017 · theses.fr (ABES)
97. BKCa channels as therapeutic targets in neurodevelopmental disorders : focus on acoustic dysfunction
    Celeste Ferraguto · 2024 · theses.fr (ABES)
98. Transcriptional–secretory uncoupling in RDEB skin creates a non-permissive microenvironment for sensory nerve regeneration
    Paula Diaz, Carolina Flores‐Muñoz, Margarita Calvo · 2026 · Neurobiology of Pain
99. MicroRNA-195: Bridging Peripheral Immune Dysfunction and Central White Matter Pathology in Schizophrenia
    Shujuan Pan, Wendi Zhang, Qianru Zhou, Xiaoyu Wang, Hu Deng, Leilei Wang, Junchao Huang, Song Chen, Zhiren Wan, Yunlong Tan et al. · 2026 · Research Square
100. BindingDB Entry 50022009: Discovery of novel indole derivatives as potent and selective inhibitors of proMMP-9 activation.
     BindingDB · 2025 · UC San Diego